Resolve Therapeutics, LLC

Biopharma innovation traditionally has been nurtured in big academic or industry laboratories. Ethan Perlstein would like to change that. After Perlstein earned his stripes in Stuart Schreiber Harva

Biopharma innovation traditionally has been nurtured in big academic or industry laboratories. Ethan Perlstein, PhD, would like to change that. After Perlstein earned his stripes in Stuart Schreiber,

Financings In the first quarter of 2013, start-up companies generated a total of $398.7 million across all industries, which was a 59% drop from the previous quarter’s $670.3 million. ( See Exhibit 1.

Elan Corp. PLC has been engaged in a slow motion strip over the past five years; it has now shed so many assets that it may soon disappear entirely. On Feb. 25, Royalty Pharma fielded an $11/sha